SEMINAR: Contraction, Contraction, Contraction

Ruth Ganss heads the Vascular Biology and Stromal Targeting Laboratory and is Scientific Head of the Cancer and Cell Biology Division at the Harry Perkins Institute of Medical Research. Her team studies vascular remodeling in the context of tumour growth and cardiovascular pathologies. During the last decades, her research at the University of California, San Francisco, the German Cancer Research Center in Heidelberg, and now at the Harry Perkins Institute has focused on blood vessels as the interface between immunology, cancer and cardiovascular disease. She pioneered the concept of vessel "normalization" which allows dramatic tumour destruction by a combination of vascular and immune therapy. Her studies aim to provide novel mechanistic insights and develop new targets for therapeutic intervention in major diseases such as cancer and hypertension.